GlassScriptPhysician profile
Angenette Taylor
NPI 1760081871
$2,289.36
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $572 · 2022: $815 · 2023: $729 · 2024: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $309.06 | 2022-2024 | Xarelto |
| Cvrx, INC. | $265.61 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $251.35 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.87 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.89 | 2021-2022 | |
| Pfizer INC. | $124.72 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $104.17 | 2022-2023 | |
| Abbvie INC. | $95.05 | 2021-2022 | |
| Amgen INC. | $93.89 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $80.20 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $61.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $55.22 | 2021-2022 | |
| Novo Nordisk INC | $54.68 | 2021-2022 | |
| Glaxosmithkline, LLC. | $44.55 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $43.25 | 2022 | |
| Vanda Pharmaceuticals INC. | $40.88 | 2021 | |
| Lilly USA, LLC | $38.38 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $32.33 | 2022 | |
| Philips North America LLC | $27.64 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.01 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.56 | 2021 | |
| Hologic Sales and Service, LLC | $19.92 | 2023 | Aptima |
| Mylan Specialty L.P. | $14.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.53 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angenette Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.